ARTEMISMED · NSE

Artemis Medicare Services Limited

₹338.5

+2.31% (+₹7.65)

Prev. close

₹330.85

Volume

3,35,686

Delivery %

43.5%

As of

18 Sept 2026

Price history

Bullish

Dharmesh Shah · ICICI Securities · 10 Aug 2026

Bullish on Artemis Medicare, recommending a buy at Rs 307–317 for a target of Rs 358, with a stop loss at Rs 284. The stock has broken out from a 15-month range, indicating upward momentum continuation after a healthy consolidation that retraced 40% of its prior uptrend.

Entry ₹307–₹317Target ₹358 (+12.9%)Stop ₹284 (-10.4%)R:R 1.2:1Live · filled 10 Aug 2026 · +7.1% since entry

Target ₹358PENDINGCall pageClear
₹338.5+₹22.55 (+7.14%) · CALL
10 Aug 202618 Sept 2026
Target ₹358SL ₹284Entry ₹315.95Entry zone ₹307₹31710 Aug20 Aug31 Aug08 Sept18 SeptCall published 06:52
Dharmesh Shah's call · 10 Aug 2026

Analyst sentiment

Analysts lean bullish

1 analyst stance · last 90 days · one per analyst

Trackable

1 · 1 bull / 0 neutral / 0 bear

Long-Horizon

none in window

Commentary

none in window

Trackable = verdict-bearing calls · Long-Horizon = 1yr+ horizon, verdict pending · Commentary = context, not graded

Bullish 100% (1)Neutral 0% (0)Bearish 0% (0)
Explore by date range →

Analyst opinions

CallAnalystInstrumentVerdictActions
Bullish on Artemis Medicare, recommending a buy at Rs 307–317 for a target of Rs 358, with a stop loss at Rs 284. The st…Dharmesh ShahICICI SecuritiesArtemis MedicarePENDING
Bullish on Artemis Medicare, recommending a buy at Rs 307–317 for a target of Rs 358, with a stop loss at Rs 284. The stock has broken out from a 15-month range, indicating upward momentum continuation after a healthy consolidation that retraced 40% of its prior uptrend.
Trade setupTarget ₹358Track opinion →

This call hasn't reached its evaluation window yet — the verdict will appear here once it's graded.

Fundamentals

About Artemis Medicare Services Limited

Artemis Medicare Services Limited engages in the management and operation of multi-specialty hospitals in India and internationally. The company provides medical and surgical intervention, mix of inpatient and outpatient services. It also offers billing and insurance, childcare, emotional and support program, full body checkup, international patient, medical interpreter and record, mind body medicine, nursing, nutrition, patient and family advisory, patient advocacy and portal, pre-admission testing, and smoking cessation program services, as well as home care services. Artemis Medicare Services Limited was incorporated in 2004 and is based in Gurugram, India.

Details

CEO

Dr. Devlina Chakravarty DMRD, DNB, M.D., Radiology

Headquarters

Gurugram

Employees

2,055

Key stats

P/E ratio (TTM)

147.8

EPS (TTM)

₹2.29

Beta (1Y · daily vs NIFTY 50)

0.89

Beta (5Y · monthly vs NIFTY 50)

2.19

Shares float

3.23 Cr

Financial Performance

01 · Financials

0 Cr500 Cr1000 Cr1500 Cr0%10%20%30%40%FY21FY22FY23FY24FY25FY26
RevenueNet incomeRevenue growth YoY

FY21 growth needs FY20 filings, which the data source doesn't provide.

02 · Earnings Per Share (EPS)

0358FY21FY22FY23FY24FY25FY26

03 · Dividend Profile

00010%0.2%0.4%0.6%14 Jul 2305 Jul 2411 Jul 2510 Jul 26
Dividend (₹/share)Annualised yieldAnnual dividend growth (FY)

Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.

08 · Profit & Loss

Annual

Line itemFY21FY22FY23FY24FY25FY26
Revenue₹408.40 Cr₹554.80 Cr₹737.43 Cr₹878.57 Cr₹936.92 Cr₹1,081.24 Cr
Net income₹6.00 Cr₹31.81 Cr₹39.00 Cr₹49.14 Cr₹82.63 Cr₹103.62 Cr
Diluted EPS₹0.49₹2.29₹2.79₹3.53₹5.31₹6.56

11 · Shareholding Pattern

NSE, quarterly

Line itemSep 21Mar 22(3Q)Jun 22Sep 22Dec 22Mar 23(2Q)Jun 23Mar 24(4Q)Jun 24Sep 24Mar 25(3Q)Jun 25Sep 25(2Q)Nov 25Dec 25Jun 26(3Q)
Promoter69.82%69.59%69.27%68.92%68.03%67.51%67.17%66.53%58.43%58.39%
Public30.18%30.41%30.73%31.08%31.97%32.49%32.83%33.47%41.57%41.61%
Employee trusts0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.

Documents

ARTEMISMED

Artemis Medicare shares gain 26% in 3 months; analysts see 30% upside

Artemis Medicare Services shares gained 26% in three months, outperforming healthcare indices. Analysts maintain a 'buy' rating, projecting over 30% upside due to the company's expansion plans. Artemis aims for 2,000 operational beds by FY30, up from 1,100, driven by new facilities and improved utilization.

ARTEMISMED

Artemis Medicare Services stock surges 26% as expansion plans boost investor confidence

Artemis Medicare Services stock has surged 26% in three months, outperforming healthcare benchmarks. The company is expanding its hospital capacity across Gurugram, Raipur, and South Delhi, targeting 2,000 operational beds by FY30. Analysts maintain a 'buy' rating, citing growth drivers like new facilities and increasing international patient mix.